{
    "clinical_study": {
        "@rank": "99171", 
        "arm_group": [
            {
                "arm_group_label": "Biological", 
                "arm_group_type": "Experimental", 
                "description": "6 weeks of  HBO treatment as well as  non weight bearing"
            }, 
            {
                "arm_group_label": "Control", 
                "arm_group_type": "Active Comparator", 
                "description": "non weight bearing"
            }
        ], 
        "brief_summary": {
            "textblock": "safety and efficacy of Hyper Baric Oxygen (HBO) in patients presenting with spontaneous\n      osteonecrosis of the knee"
        }, 
        "brief_title": "Hyper Baric Oxygen Therapy (HBOT) for Spontaneous Osteonecrosis of the Knee", 
        "completion_date": {
            "#text": "August 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Spontaneous Osteonecrosis of the Knee", 
        "condition_browse": {
            "mesh_term": "Osteonecrosis"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Age40-85 years\n\n          -  Diagnosis of Spontaneous osteonecrosis of the knee (SONK)in last month, Stage 1 or 2\n             by MRI.\n\n        Exclusion Criteria:\n\n          -  Hyperbaric treatment (HBOT) in the last 2 years.\n\n          -  Any contraindication for HBOT\n\n          -  Pregnancy.\n\n          -  Inability to sign inform consent\n\n          -  Any contraindication for MRI"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "85 Years", 
            "minimum_age": "40 Months"
        }, 
        "enrollment": {
            "#text": "40", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "August 28, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01950858", 
            "org_study_id": "91/12*1"
        }, 
        "intervention": {
            "arm_group_label": [
                "Biological", 
                "Control"
            ], 
            "intervention_name": "Weight reduction", 
            "intervention_type": "Biological"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "September 19, 2013", 
        "location": {
            "contact": {
                "email": "yiftah.beer@gmail.com", 
                "last_name": "Yiftah Beer, MD", 
                "phone": "972-8-9779432"
            }, 
            "facility": {
                "address": {
                    "city": "Zerifin", 
                    "country": "Israel", 
                    "zip": "70300"
                }, 
                "name": "Assaf-Harofeh Medical Center"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Israel"
        }, 
        "number_of_arms": "2", 
        "official_title": "Safety and Efficacy of Hyper Baric Oxygen Therapy (HBOT) in Patients Presenting With Spontaneous Osteonecrosis of the Knee", 
        "overall_contact": {
            "email": "yiftah.beer@gmail.com", 
            "last_name": "Yiftah Beer, MD", 
            "phone": "972-8-9779432"
        }, 
        "overall_official": {
            "affiliation": "Assaf-Harofeh Medical Center", 
            "last_name": "Shai Efrati, MD", 
            "role": "Study Chair"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Israel: Ministry of Health", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 1", 
        "primary_completion_date": {
            "#text": "May 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "description": "Pain Reduction", 
                "measure": "Efficacy", 
                "safety_issue": "No", 
                "time_frame": "6 weeks"
            }, 
            {
                "description": "Number of Participants with Adverse Events during HBOT", 
                "measure": "Safety", 
                "safety_issue": "Yes", 
                "time_frame": "end of HBOT"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01950858"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Assaf-Harofeh Medical Center", 
            "investigator_full_name": "Assaf Harofeh MC", 
            "investigator_title": "Yiftah Beer", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "measure": "Reduction In AVN size by  MRI", 
            "safety_issue": "No", 
            "time_frame": "6 weeks"
        }, 
        "source": "Assaf-Harofeh Medical Center", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Assaf-Harofeh Medical Center", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "May 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "September 2013"
    }
}